Katalog der Deutschen Nationalbibliothek

Gesamter Bestand

Musikarchiv

Buchmuseum

Suchformular zurücksetzen

Expertensuche ?

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

Noch nicht die passende Literatur gefunden? → Book a Librarian

Ergebnis der Suche nach: auRef=1067780025
im Bestand: Gesamter Bestand

1 - 10 von 10

	1	Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations Eckardt, Jan‑Niklas. - Dresden : Technische Universität Dresden, 2024
	2	Palbociclib in acute leukemias with KMT2A-rearrangement: results of AMLSG 23-14 trial Gaidzik, Verena Ingeborg. - Freiburg : Universität, 2023
	3	Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study Middeke, Jan Moritz. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2022
	4	Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation Kunadt, Désirée. - Aachen : Universitätsbibliothek der RWTH Aachen, 2022
	5	Carcinoma of Unknown Primary – an Orphan Disease? Krämer, Alwin. - Dresden : Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, 2014
	6	High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders Enthalten in Leukemia Bd. 37, 11.10.2023, Nr. 12, date:12.2023: 2468-2478
	7	Human SLFN5 and its Xenopus Laevis ortholog regulate entry into mitosis and oocyte meiotic resumption Enthalten in Cell death discovery Bd. 8, 8.12.2022, Nr. 1, date:12.2022: 1-12
	8	Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation Enthalten in Journal of hematology & oncology Bd. 15, 5.9.2022, Nr. 1, date:12.2022: 1-15
	9	Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations Enthalten in Journal of hematology & oncology Bd. 15, 13.5.2022, Nr. 1, date:12.2022: 1-13
	10	Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial Enthalten in Nature Communications Bd. 14, 24.10.2023, Nr. 1, date:12.2023: 1-21

1 - 10 von 10

Alle Materialarten

Alle Standorte

Aktionen